Bristol Myers Squibb · Total Non-Current Liabilities

Latest reported$48.12Bperiod endingDec 31, 2025

BMY FY Total Non-Current Liabilities ($630.00M → $48.12B)

Annual total non-current liabilities

High-resolution chart · PNG

BMY total non-current liabilities history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb Total Non-Current Liabilities — Annual fiscal periods (USD)
Period ending	Total Non-Current Liabilities (USD)
Dec 31, 2025	48,115,000,000
Dec 31, 2024	52,441,000,000
Dec 31, 2023	43,412,000,000
Dec 31, 2022	43,812,000,000
Dec 31, 2021	51,440,000,000
Dec 31, 2020	61,519,000,000
Dec 31, 2019	59,942,000,000
Dec 31, 2018	10,205,000,000
Dec 31, 2017	12,141,000,000
Dec 31, 2016	8,519,000,000
Dec 31, 2015	9,307,000,000
Dec 31, 2014	10,305,000,000
Dec 31, 2013	10,916,000,000
Dec 31, 2012	13,980,000,000
Dec 31, 2011	9,323,000,000
Dec 31, 2010	8,699,000,000
Dec 31, 2009	9,910,000,000
Dec 31, 2008	10,568,000,000
Dec 31, 2007	6,966,000,000
Dec 31, 2006	9,088,000,000
Dec 31, 2005	10,040,000,000
Dec 31, 2004	10,390,000,000
Dec 31, 2003	10,201,000,000
Dec 31, 2002	7,779,000,000
Dec 31, 2001	7,628,000,000
Dec 31, 2000	2,766,000,000
Dec 31, 1999	2,932,000,000
Dec 31, 1998	2,905,000,000
Dec 31, 1997	2,726,000,000
Dec 31, 1996	3,065,000,000
Dec 31, 1995	3,301,000,000
Dec 31, 1994	2,932,000,000
Dec 31, 1993	3,096,000,000
Dec 31, 1992	1,484,000,000
Dec 31, 1991	869,000,000
Dec 31, 1990	976,000,000
Dec 31, 1989	754,000,000
Dec 31, 1988	712,000,000
Dec 31, 1987	630,000,000